Drugs Made In America Acquisiti
DMAA
Last
$10.88
Day
+0.3%
1y
+5.5%
5y
+8.9%
52w
-0.4%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
10.84
EMA 50
10.78
EMA 200
10.58
20d high
-0.4%
5y high
-0.4%
5y range
96th
Positions held
Your positionsDMAA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
23
Hold
swing
Signal
Buy
Target
$10.92
Stop
$10.81
Stop distance
0.6%
Target vs last
+0.4%
Fundamentals
| Market cap | $263.40M | Enterprise value | $263.73M | Trailing P/E | 60.28 | Forward P/E | — |
| PEG | — | Price / book | -35.57 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | -17.9% | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 0.02 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $10.89 | 52w low | $10.26 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | $1.7M | $2.0M | $0.2M | $2.2M | $2.3M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$0.1M | -$0.1M | -$2.1M | -$0.3M | -$0.1M | — |
Yearly (6y)
| 2025 | |
|---|---|
| Revenue | $0.0M |
| Op margin | — |
| Net income | $5.9M |
| Gross margin | — |
| Gross profit | — |
| Operating income | -$2.8M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsDMAA · daily+0.1% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin